Metropolitan Life Insurance Company (MetLife)’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-517
| Closed | -$13.2K | – | 307 |
|
|
2024
Q1 | $13.2K | Buy |
517
+344
| +199% | +$8.82K | ﹤0.01% | 2031 |
|
|
2023
Q4 | $4.78K | Sell |
173
-108
| -38% | -$6.58K | ﹤0.01% | 2288 |
|
|
2023
Q3 | $17.1K | Hold |
281
| – | – | ﹤0.01% | 1971 |
|
|
2023
Q2 | $18.5K | Hold |
281
| – | – | ﹤0.01% | 1976 |
|
|
2023
Q1 | $17.8K | Buy |
281
+24
| +9% | +$2.74K | ﹤0.01% | 1942 |
|
|
2022
Q4 | $35.6K | Buy |
257
+23
| +10% | +$3.24K | ﹤0.01% | 1689 |
|
|
2022
Q3 | $29.6K | Buy |
234
+138
| +144% | +$15.6K | ﹤0.01% | 1804 |
|
|
2022
Q2 | $7.98K | Sell |
96
-129
| -57% | -$10K | ﹤0.01% | 2325 |
|
|
2022
Q1 | $21.9K | Sell |
225
-679
| -75% | -$89.6K | ﹤0.01% | 2046 |
|
|
2021
Q4 | $181K | Sell |
904
-544
| -38% | -$128K | ﹤0.01% | 2098 |
|
|
2021
Q3 | $358K | Hold |
1,448
| – | – | 0.01% | 1660 |
|
|
2021
Q2 | $600K | Buy |
1,448
+1,225
| +549% | +$485K | 0.01% | 1394 |
|
|
2021
Q1 | $87.2K | Sell |
223
-5
| -2% | -$2.46K | ﹤0.01% | 2462 |
|
|
2020
Q4 | $128K | Sell |
228
-6
| -3% | -$3.8K | ﹤0.01% | 2221 |
|
|
2020
Q3 | $163K | Hold |
234
| – | – | ﹤0.01% | 1911 |
|
|
2020
Q2 | $185K | Buy |
234
+131
| +127% | +$98.8K | ﹤0.01% | 1857 |
|
|
2020
Q1 | $61.4K | Hold |
103
| – | – | ﹤0.01% | 2316 |
|
|
2019
Q4 | $117K | Hold |
103
| – | – | ﹤0.01% | 2239 |
|
|
2019
Q3 | $122K | Sell |
103
-140
| -58% | -$214K | ﹤0.01% | 2190 |
|
|
2019
Q2 | $401K | Sell |
243
-5
| -2% | -$8.65K | 0.01% | 1444 |
|
|
2019
Q1 | $506K | Sell |
248
-5
| -2% | -$8.8K | 0.01% | 1289 |
|
|
2018
Q4 | $325K | Sell |
253
-1
| -0.4% | -$1.53K | 0.01% | 1496 |
|
|
2018
Q3 | $480K | Buy |
254
+12
| +5% | +$24.8K | 0.01% | 1384 |
|
|
2018
Q2 | $492K | Sell |
242
-940
| -80% | -$2.14M | 0.01% | 1324 |
|
|
2018
Q1 | $2.62M | Buy |
1,182
+41
| +4% | +$104K | 0.04% | 386 |
|
|
2017
Q4 | $2.63M | Sell |
1,141
-1,215
| -52% | -$2.47M | 0.04% | 381 |
|
|
2017
Q3 | $4.19M | Buy |
2,356
+187
| +9% | +$261K | 0.03% | 677 |
|
|
2017
Q2 | $2.95M | Hold |
2,169
| – | – | 0.02% | 829 |
|
|
2017
Q1 | $2.55M | Sell |
2,169
-32
| -1% | -$32.6K | 0.02% | 871 |
|
|
2016
Q4 | $1.76M | Buy |
2,201
+156
| +8% | +$124K | 0.01% | 1021 |
|
|
2016
Q3 | $1.79M | Sell |
2,045
-43
| -2% | -$31.1K | 0.01% | 991 |
|
|
2016
Q2 | $1.17M | Buy |
2,088
+1,881
| +909% | +$1.07M | 0.01% | 1171 |
|
|
2016
Q1 | $114K | Hold |
207
| – | – | ﹤0.01% | 2411 |
|
|
2015
Q4 | $172K | Buy |
207
+6
| +3% | +$5.99K | ﹤0.01% | 2356 |
|
|
2015
Q3 | $223K | Buy |
201
+16
| +9% | +$29.2K | ﹤0.01% | 2216 |
|
|
2015
Q2 | $403K | Sell |
185
-1,284
| -87% | -$2.62M | ﹤0.01% | 1896 |
|
|
2015
Q1 | $2.3M | Buy |
1,469
+136
| +10% | +$179K | 0.02% | 852 |
|
|
2014
Q4 | $1.58M | Hold |
1,333
| – | – | 0.01% | 1062 |
|
|
2014
Q3 | $619K | Buy |
1,333
+181
| +16% | +$83.5K | ﹤0.01% | 1583 |
|
|
2014
Q2 | $576K | Buy |
+1,152
| New | +$369K | ﹤0.01% | 1734 |
|
|
2013
Q4 | – | Sell |
-624
| Closed | -$218K | – | 2739 |
|
|
2013
Q3 | $218K | Buy |
+624
| New | +$232K | ﹤0.01% | 2360 |
|
Other funds holding BLUE
PAI
Metropolitan Life Insurance Company (MetLife)'s BLUE Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 517 shares — an estimated $13.2K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BLUE in Q3 2013 and held it in 41 quarters. The position peaked at $4.19M in Q3 2017. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 517 bluebird bio shares in Q2 2024, an estimated $13.2K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in bluebird bio in Q3 2013 and held it in 41 quarters.
- Metropolitan Life Insurance Company (MetLife)'s bluebird bio position peaked at $4.19M in Q3 2017.
- 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.